These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31070153)
21. Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation. Ergan B; Şahin AA; Topeli A Respiration; 2016; 91(4):316-24. PubMed ID: 27081845 [TBL] [Abstract][Full Text] [Related]
22. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation. Lindenauer PK; Shieh MS; Stefan MS; Fisher KA; Haessler SD; Pekow PS; Rothberg MB; Krishnan JA; Walkey AJ Ann Am Thorac Soc; 2017 Dec; 14(12):1779-1785. PubMed ID: 28795838 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis. Hoult G; Gillespie D; Wilkinson TMA; Thomas M; Francis NA BMC Pulm Med; 2022 May; 22(1):194. PubMed ID: 35549921 [TBL] [Abstract][Full Text] [Related]
24. The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update. Pantzaris ND; Spilioti DX; Psaromyalou A; Koniari I; Velissaris D J Clin Med Res; 2018 Jul; 10(7):545-551. PubMed ID: 29904438 [TBL] [Abstract][Full Text] [Related]
25. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits. Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728 [TBL] [Abstract][Full Text] [Related]
26. The predictive value of serum procalcitonin for non-invasive positive pressure ventilation in the patients with acute exacerbation of chronic obstructive pulmonary disease. Liu L; Luan Y; Xiao L; Wang N; Wang J; Cui Z Medicine (Baltimore); 2021 Apr; 100(16):e25547. PubMed ID: 33879703 [TBL] [Abstract][Full Text] [Related]
27. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD. Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274 [TBL] [Abstract][Full Text] [Related]
28. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382 [TBL] [Abstract][Full Text] [Related]
29. Procalcitonin and antibiotics in moderate-severe acute exacerbation of chronic obstructive pulmonary disease: to use or not to use. Chan HP; Lim TK Curr Opin Pulm Med; 2019 Mar; 25(2):150-157. PubMed ID: 30418243 [TBL] [Abstract][Full Text] [Related]
30. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens. Kawamatawong T; Apiwattanaporn A; Siricharoonwong W Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA PVT1, a novel biomarker for chronic obstructive pulmonary disease progression surveillance and acute exacerbation prediction potentially through interaction with microRNA-146a. Wang Y; Lyu X; Wu X; Yu L; Hu K J Clin Lab Anal; 2020 Aug; 34(8):e23346. PubMed ID: 32342557 [TBL] [Abstract][Full Text] [Related]
32. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial. Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210 [TBL] [Abstract][Full Text] [Related]
33. The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation. Gao D; Chen X; Wu H; Wei H; Wu J Exp Ther Med; 2017 Jul; 14(1):193-198. PubMed ID: 28672914 [TBL] [Abstract][Full Text] [Related]
34. Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD. Çolak A; Yılmaz C; Toprak B; Aktoğu S J Med Biochem; 2017 Apr; 36(2):122-126. PubMed ID: 28680355 [TBL] [Abstract][Full Text] [Related]
35. Introduction of a PCT-based algorithm to guide antibiotic prescription in COPD exacerbation. Picart J; Moiton MP; Gaüzère BA; Gazaille V; Combes X; DiBernardo S Med Mal Infect; 2016 Dec; 46(8):429-435. PubMed ID: 27609596 [TBL] [Abstract][Full Text] [Related]
36. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity]. Liu H; Xu JY Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993 [TBL] [Abstract][Full Text] [Related]
37. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients]. Jiang M; Ma JF Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of Galectin-3 in Exacerbations of Chronic Obstructive Pulmonary Disease. Berber NK; Atlı S; Geçkil AA; Erdem M; Kıran TR; Otlu Ö; İn E Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674175 [No Abstract] [Full Text] [Related]
39. Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Ulrich RJ; McClung D; Wang BR; Winters S; Flanders SA; Rao K Infect Dis (Auckl); 2019; 12():1178633719852626. PubMed ID: 31223234 [TBL] [Abstract][Full Text] [Related]
40. [Prevalence of vitamin D deficiency and impact on quality of life in patients with chronic obstructive pulmonary disease]. Zhang P; Luo H; Zhu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):802-6. PubMed ID: 22954915 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]